Study could pave the way for synergistic therapeutic combinations to better treat SF3B1-mutant MDS

A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms.

UK regulator proposes recognizing overseas medical device approvals

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.K. Medicines and Healthcare

May 24, 2024

Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer

MedPage Today brought together three expert leaders in the field — moderator Susana Campos, MD, from the Dana-Farber Cancer Institute in Boston, is joined by

December 1, 2023

IU researchers receive $5 million grant to improve care for adolescents with opioid use disorder

IU School of Medicine researchers are taking steps to improve the accessibility and quality of care for adolescents experiencing opioid use disorder (OUD) and other

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.